Raxar

Active Ingredient(s): Grepafloxacin
FDA Approved: * November 6, 1997
Pharm Company: * OTSUKA
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Raxar Overview

Grepafloxacin (trade name Raxar, Glaxo Wellcome) was an oral broad-spectrum fluoroquinolone antibacterial agent used to treat bacterial infections. Grepafloxacin was withdrawn worldwide from markets in 1999,[1][2] due to its side effect of lengthening the QT interval on the electrocardiogram, leading to cardiac events and sudden death.[3] Contents 1 Clinical uses 2 Synthesis 3 Stereochemistry 4 See also 5 References Clinical uses Grepa...

Read more Raxar Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Grepafloxacin

Recent Raxar Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Grepafloxacin
  • Tablet: 200mg, 400mg, 600mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Grepafloxacin or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA